151 related articles for article (PubMed ID: 35380292)
1. PPARγ alleviates peritoneal fibrosis progression along with promoting GLUT1 expression and suppressing peritoneal mesothelial cell proliferation.
Feng J; Lu M; Li W; Li J; Meng P; Li Z; Gao X; Zhang Y
Mol Cell Biochem; 2022 Jul; 477(7):1959-1971. PubMed ID: 35380292
[TBL] [Abstract][Full Text] [Related]
2. [High glucose dialysate enhances peritoneal fibrosis through upregulating glucose transporters GLUT1 and SGLT1].
Hong M; Nie Z; Chen Z; Yu X; Bao B
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 May; 45(6):598-606. PubMed ID: 28247603
[TBL] [Abstract][Full Text] [Related]
3. Quantitative characterization of 15-deoxy-delta(12,14)-prostaglandin J2 in regulating EGFPSmad2 translocation in CHO cells through PPARgamma/TGFbeta/Smad2 pathway.
Ye F; Sun T; Luo H; Ding H; Chen K; Shen X; Jiang H
Cell Physiol Biochem; 2006; 18(1-3):143-50. PubMed ID: 16914899
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator-activated receptor gamma ligands stimulate endothelial nitric oxide production through distinct peroxisome proliferator-activated receptor gamma-dependent mechanisms.
Polikandriotis JA; Mazzella LJ; Rupnow HL; Hart CM
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1810-6. PubMed ID: 16020752
[TBL] [Abstract][Full Text] [Related]
5. The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines.
Morosetti R; Servidei T; Mirabella M; Rutella S; Mangiola A; Maira G; Mastrangelo R; Koeffler HP
Int J Oncol; 2004 Aug; 25(2):493-502. PubMed ID: 15254749
[TBL] [Abstract][Full Text] [Related]
6. Contrasting effects of peroxisome-proliferator-activated receptor (PPAR)gamma agonists on membrane-associated prostaglandin E2 synthase-1 in IL-1beta-stimulated rat chondrocytes: evidence for PPARgamma-independent inhibition by 15-deoxy-Delta12,14prostaglandin J2.
Bianchi A; Moulin D; Sebillaud S; Koufany M; Galteau MM; Netter P; Terlain B; Jouzeau JY
Arthritis Res Ther; 2005; 7(6):R1325-37. PubMed ID: 16277686
[TBL] [Abstract][Full Text] [Related]
7. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer.
Lin MS; Chen WC; Bai X; Wang YD
J Dig Dis; 2007 May; 8(2):82-8. PubMed ID: 17532820
[TBL] [Abstract][Full Text] [Related]
8. PPARgamma agonists inhibit TGF-beta induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis.
Burgess HA; Daugherty LE; Thatcher TH; Lakatos HF; Ray DM; Redonnet M; Phipps RP; Sime PJ
Am J Physiol Lung Cell Mol Physiol; 2005 Jun; 288(6):L1146-53. PubMed ID: 15734787
[TBL] [Abstract][Full Text] [Related]
9. PPAR gamma ligands, 15-deoxy-delta12,14-prostaglandin J2 and rosiglitazone regulate human cultured airway smooth muscle proliferation through different mechanisms.
Ward JE; Gould H; Harris T; Bonacci JV; Stewart AG
Br J Pharmacol; 2004 Feb; 141(3):517-25. PubMed ID: 14718259
[TBL] [Abstract][Full Text] [Related]
10. Agonists at PPAR-gamma suppress angiotensin II-induced production of plasminogen activator inhibitor-1 and extracellular matrix in rat cardiac fibroblasts.
Hao GH; Niu XL; Gao DF; Wei J; Wang NP
Br J Pharmacol; 2008 Apr; 153(7):1409-19. PubMed ID: 18278065
[TBL] [Abstract][Full Text] [Related]
11. PPAR-γ agonist rosiglitazone protects peritoneal membrane from dialysis fluid-induced damage.
Sandoval P; Loureiro J; González-Mateo G; Pérez-Lozano ML; Maldonado-Rodríguez A; Sánchez-Tomero JA; Mendoza L; Santamaría B; Ortiz A; Ruíz-Ortega M; Selgas R; Martín P; Sánchez-Madrid F; Aguilera A; López-Cabrera M
Lab Invest; 2010 Oct; 90(10):1517-32. PubMed ID: 20531289
[TBL] [Abstract][Full Text] [Related]
12. [Effect of peroxisome proliferators-activated receptor-gamma in the mechanisms of sulindac against large intestine carcinoma].
Li CF; Lv YM; Ni JH; Li J
Beijing Da Xue Xue Bao Yi Xue Ban; 2007 Feb; 39(1):72-6. PubMed ID: 17304332
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor-gamma is expressed by rat peritoneal mesothelial cells: its potential role in peritoneal cavity local defense.
Zhang YF; Yang X; Zhang YJ; Sun YL; Zou XL; Kong QY; Dong XQ; Ye XQ; Yu XQ
Am J Nephrol; 2006; 26(6):602-11. PubMed ID: 17183189
[TBL] [Abstract][Full Text] [Related]
14. Rosiglitazone inhibits metastasis development of a murine mammary tumor cell line LMM3.
Magenta G; Borenstein X; Rolando R; Jasnis MA
BMC Cancer; 2008 Feb; 8():47. PubMed ID: 18261208
[TBL] [Abstract][Full Text] [Related]
15. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.
Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Patel NS; Di Paola R; Genovese T; Chatterjee PK; Di Rosa M; Caputi AP; Thiemermann C
Br J Pharmacol; 2003 Sep; 140(2):366-76. PubMed ID: 12970094
[TBL] [Abstract][Full Text] [Related]
16. Effects of peroxisome proliferator-activated receptor gamma agonists on brain glucose and glutamate transporters after stress in rats.
García-Bueno B; Caso JR; Pérez-Nievas BG; Lorenzo P; Leza JC
Neuropsychopharmacology; 2007 Jun; 32(6):1251-60. PubMed ID: 17119541
[TBL] [Abstract][Full Text] [Related]
17. Telmisartan attenuates peritoneal fibrosis via peroxisome proliferator-activated receptor-γ activation in rats.
Su X; Yu R; Yang X; Zhou G; Wang Y; Li L; Li D
Clin Exp Pharmacol Physiol; 2015 Jun; 42(6):671-9. PubMed ID: 25867712
[TBL] [Abstract][Full Text] [Related]
18. Troglitazone inhibits synthesis of transforming growth factor-beta1 and reduces matrix production in human peritoneal mesothelial cells.
Peng Y; Liu H; Liu F; Liu Y; Li J; Chen X
Nephrology (Carlton); 2006 Dec; 11(6):516-23. PubMed ID: 17199790
[TBL] [Abstract][Full Text] [Related]
19. The peroxisome proliferator-activated receptor gamma (PPARgamma) ligands 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone induce human B lymphocyte and B cell lymphoma apoptosis by PPARgamma-independent mechanisms.
Ray DM; Akbiyik F; Phipps RP
J Immunol; 2006 Oct; 177(8):5068-76. PubMed ID: 17015690
[TBL] [Abstract][Full Text] [Related]
20. Effects of 15-deoxy-delta12,14-prostaglandin J2 (15d-PGJ2) and rosiglitazone on human gammadelta2 T cells.
Li H; Pauza CD
PLoS One; 2009 Nov; 4(11):e7726. PubMed ID: 19888466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
